annb0t
Top 20
Biomedical Advanced Research and Development Authority (BARDA) has modified its contract with AVITA Medical Inc (NASDAQ: RCEL) to support its clinical trial in soft tissue reconstruction.
AVITA Medical is currently completing a pivotal trial to use the RECELL System for soft tissue reconstruction. Currently, the RECELL System is indicated in the U.S. to treat acute thermal burns. Related:AVITA Medical Inks Supply Pact With Premier For RECELL System. The clinical trial will compare the clinical ...
>>> Read more: AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction
AVITA Medical is currently completing a pivotal trial to use the RECELL System for soft tissue reconstruction. Currently, the RECELL System is indicated in the U.S. to treat acute thermal burns. Related:AVITA Medical Inks Supply Pact With Premier For RECELL System. The clinical trial will compare the clinical ...
>>> Read more: AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction
